Study of NKTR 255 in Combination With Cetuximab in Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Head and Neck Squamous Cell Carcinoma
Related studies linked through entity extraction aliases.
Real-time Detection of ctDNA and/or HPV DNA in High-risk Locally-advanced Head and Neck Squamous Cell Carcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Specific Methylation Profiles in HNSCC
- Status
- RECRUITING
- Phase
- N/A
Prospective Observational Study to Validate Circulating HPVDNA and Prognostic Genomic Biomarkers in HPV-associated OPSCC
- Status
- RECRUITING
- Phase
- N/A
Alisertib and Pembrolizumab for the Treatment of Patients With Rb-deficient Head and Neck Squamous Cell Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Phonosurgical Augmentation After Laser Resection of Early Glottic Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Concurrent Immunotherapy With Postoperative Radiotherapy in Intermediate/High Risk HNSCC Patients Unfit for Cisplatin: The IMPORT Study (IMPORT)
- Status
- UNKNOWN
- Phase
- PHASE2
Validation of Molecular Diagnostic Assays to Detect Cancer Biomarkers in Blood and Primary Tumor in HNSCC/NSCLC/Melanoma
- Status
- COMPLETED
- Phase
- N/A
Safety and Preliminary Efficacy of SNK01 in Combination With Trastuzumab or Cetuximab in Subjects With Advanced HER2 or EGFR Cancers
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
A Study of the Safety and Tolerance of CAN04 and Pembrolizumab in Combination With and Without Carboplatin and Pemetrexed in Subjects With Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Prospective Pilot Study Evaluating Dental Side Effects of Radiotherapy on Subjects Treated for Head and Neck Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Study of NM21-1480 in Adult Patients With Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Camrelizumab Combined With Apatinib Mesylate for Head and Neck Squamous Cell Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE2
Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
Combining Pembrolizumab and Metformin in Metastatic Head and Neck Cancer Patients
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Carrimycin in Patients With Locally Advanced, Recurrent, or Metastatic HNSCC (Non NPC): A Phase I Trial
- Status
- COMPLETED
- Phase
- PHASE1
Phase II Study for Combination of Camrelizumab and SBRT in the First-line Treatment for R/M HNSCC
- Status
- UNKNOWN
- Phase
- PHASE2
Cetuximab After Immunotherapy for the Treatment of Head and Neck Squamous Cell Cancer
- Status
- RECRUITING
- Phase
- PHASE2
HPV-16 Vaccination and Pembrolizumab Plus Cisplatin for "Intermediate Risk" HPV-16-associated Head and Neck Squamous Cell Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Efficacy of Immunotherapy Plus a Drug in Patients With Progressive Advanced Mucosal Cancer of Different Locations
- Status
- COMPLETED
- Phase
- PHASE2